Business of Medicine
Livin' on the MDedge
Please interrupt me, but don't heat your fish
Plus, the latest TikTok trend has people “running to the bathroom.”
Feature
Diabetes drug’s new weight-loss indication fuels cost-benefit debate
Health plans’ coverage of semaglutide, branded as Wegovy – which has a $1,300-a-month price tag – is not a sure thing.
Latest News
Physicians wearing white coats rated more experienced
Physicians wearing white coats were rated more experienced and professional than peers in casual attire, while female physicians uniformly were...
From the Journals
FDA’s fast-track approval process exposed as lax, in need of reform
Once drugs are approved through this pathway, they are rarely taken off the market, a new study finds.
Feature
COVID-19 leaves wake of medical debt among U.S. adults
Plus, 16% of adults said they had coverage gaps lasting a year or longer.
Livin' on the MDedge
Money buys life, and a cigarette maker wants to ‘unsmoke the world’
Plus, an autopsy gets interrupted by the patient, and the pandemic gets competitive.
Feature
Are you at legal risk for speaking at conferences?
Attorneys say participants who sign agreements to speak at conferences should be aware of all their rights and responsibilities.
Commentary
MDs rebut claims of toxic culture after resident suicides
Dr. Pamela Wible “misrepresented our residency program and made numerous statements that are false and simply hurtful,” [Dr. Dimitrov and Dr....
From the Journals
Direct oral anticoagulants: Competition brought no cost relief
Medicare Part D spending since 2011 has far outpaced growth in the use of oral anticoagulants.
Latest News
Mayo, Cleveland Clinics top latest U.S. News & World Report hospital rankings
With new ratings for myocardial infarction, stroke, hip fracture, and back surgery (spinal fusion), the report now ranks 17 procedures and...
Livin' on the MDedge
Lucid abductions and Candy Crush addiction
Plus, coffee gets credit for heart health and a world leader gets hiccups.